Common coupling map advances GPCR-G protein selectivity

Elife. 2022 Mar 18:11:e74107. doi: 10.7554/eLife.74107.

Abstract

Two-thirds of human hormones and one-third of clinical drugs act on membrane receptors that couple to G proteins to achieve appropriate functional responses. While G protein transducers from literature are annotated in the Guide to Pharmacology database, two recent large-scale datasets now expand the receptor-G protein 'couplome'. However, these three datasets differ in scope and reported G protein couplings giving different coverage and conclusions on G protein-coupled receptor (GPCR)-G protein signaling. Here, we report a common coupling map uncovering novel couplings supported by both large-scale studies, the selectivity/promiscuity of GPCRs and G proteins, and how the co-coupling and co-expression of G proteins compare to the families from phylogenetic relationships. The coupling map and insights on GPCR-G protein selectivity will catalyze advances in receptor research and cellular signaling toward the exploitation of G protein signaling bias in design of safer drugs.

Keywords: G protein; GPCR; computational biology; human; pharmacology; signal transduction; systems biology.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • GTP-Binding Proteins / genetics
  • GTP-Binding Proteins / metabolism
  • Humans
  • Phylogeny
  • Receptors, G-Protein-Coupled* / genetics
  • Receptors, G-Protein-Coupled* / metabolism
  • Signal Transduction* / physiology

Substances

  • Receptors, G-Protein-Coupled
  • GTP-Binding Proteins

Grants and funding